Clinical Data, Safety and Statistical Centers (CDSSC)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Institute of Allergy and Infectious Diseases is preparing to award a contract under the Clinical Data, Safety and Statistical Centers program to support the design, implementation, and analysis of clinical research across three key disease areas: asthma and allergy, autoimmune diseases, and transplantation. This initiative will provide comprehensive coordination and oversight for multiple clinical networks funded by NIAID, ensuring robust statistical design, protocol development, study management, data handling, safety monitoring, sample tracking, and final analysis of results. The program also includes support for manuscript development to facilitate timely dissemination of scientific findings. The centers will serve as critical infrastructure for advancing mechanistic studies and clinical trials, enabling high-quality, efficient research across NIAID’s Division of Allergy, Immunology, and Transplantation. The opportunity is forecasted under authorities granted by Sections 301 and 405 of the Public Health Service Act and relevant federal regulations, with the point of contact being the Division of Allergy, Immunology, and Transplantation via cdsscc_um1@mail.nih.gov.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission through the support of the Clinical Data, Safety and Statistical Centers program. The overall objective of this program is to provide coordination and oversight for multiple activities in service to clinical research and mechanistic studies supported by NIAID, including all Division of Allergy, Immunology, and Transplantation’s Clinical Network activities. This program will provide a broad range of support critical for the design, development, implementation, and analysis of clinical research carried out by multiple division-supported programs in three disease areas: asthma and allergy, autoimmune diseases and transplantation. Support will include statistical design and analysis, protocol development, study initiation and management, data management, safety monitoring, sample tracking, final analysis of study findings, and manuscript development. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.
